On 03 November 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276.SH) repurchased 100,000 A shares on the Shanghai Stock Exchange. The repurchase price ranged from RMB 63 to RMB 63.28 per share, totaling RMB 6,322,300. These shares are held as treasury shares for the A Share Employee Stock Ownership Schemes.
Following this transaction, the number of issued A shares (excluding treasury shares) stood at 6,362,632,164, and the total treasury shares increased to 16,370,110. The total number of issued shares remained at 6,379,002,274.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.